Fcf Advisors LLC Illumina, Inc. Transaction History

Fcf Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 06, 2021	SELL	$361.28 - $504.76 $1.58 Million - $2.21 Million	-4,376 Closed	0 $0
Q4 2020 Jan 12, 2021	SELL	$292.7 - $370.96 $118,543 - $150,238	-405 Reduced 8.47%	4,376 $1.61 Million
Q3 2020 Oct 20, 2020	BUY	$268.51 - $400.74 $456,735 - $681,658	1,701 Added 55.23%	4,781 $1.62 Million
Q2 2020 Jul 10, 2020	SELL	$256.46 - $373.01 $271,334 - $394,644	-1,058 Reduced 25.57%	3,080 $1.15 Million
Q1 2020 Apr 21, 2020	SELL	$209.2 - $335.53 $160,665 - $257,687	-768 Reduced 15.65%	4,138 $1.11 Million
Q4 2019 Jan 07, 2020	SELL	$288.29 - $335.49 $32,865 - $38,245	-114 Reduced 2.27%	4,906 $1.63 Million
Q3 2019 Oct 09, 2019	BUY	$266.84 - $378.23 $3,202 - $4,538	12 Added 0.24%	5,020 $1.53 Million
Q2 2019 Jul 08, 2019	SELL	$300.59 - $368.15 $171,336 - $209,845	-570 Reduced 10.22%	5,008 $1.84 Million
Q1 2019 Apr 09, 2019	BUY	$272.57 - $321.18 $72,503 - $85,433	266 Added 5.01%	5,578 $1.73 Million
Q4 2018 Jan 15, 2019	BUY	$272.46 - $366.54 $1.02 Million - $1.37 Million	3,750 Added 240.08%	5,312 $1.59 Million
Q3 2017 Dec 01, 2017	BUY	$172.3 - $213.93 $269,132 - $334,158	1,562	1,562 $311,000

960

153M

1.78M

1.46M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $15.8B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Fcf Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Fcf Advisors LLC with notifications on news.